Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and Neck.

Nemunaitis, John; Clayman, Gary; Agarwala, Sanjiv S; Hrushesky, William; Wells, James R; Moore, Charles; Hamm, John; Yoo, George; Baselga, Jose; Murphy, Barbara A; Menander, Kerstin A; Licato, Laura L; Chada, Sunil; Gibbons, Robert D; Olivier, Magali; Hainaut, Pierre; Roth, Jack A; Sobol, Robert E; Goodwin, W Jarrard

Nemunaitis, John; Clayman, Gary; Agarwala, Sanjiv S; Hrushesky, William; Wells, James R; Moore, Charles; Hamm, John; Yoo, George; Baselga, Jose; Murphy, Barbara A; Menander, Kerstin A; Licato, Laura L; Chada, Sunil; Gibbons, Robert D; Olivier, Magali; Hainaut, Pierre; Roth, Jack A; Sobol, Robert E; Goodwin, W Jarrard.

Afiliación

Nemunaitis J; Authors' Affiliations: Mary Crowley Cancer Research Centers, Dallas, Texas; The University of Texas M.D. Anderson Cancer Center; Introgen Therapeutics, Houston, Texas; St. Luke's Cancer Center, Bethlehem, Pennsylvania; WJB Dorn Veterans Affairs Medical Center, Columbia, South Carolina; Emory University School of Medicine, Atlanta, Georgia; University of Louisville, Louisville, Kentucky; Wayne State University, Detroit, Michigan; Hospital General Universitario Vall d' Hebron, Barcelona, Spain; Va

Clin Cancer Res ; 15(24): 7719-7725, 2009 Dec 15.

Article en En | MEDLINE | ID: mdl-19996201

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2009 Tipo del documento: Article Pais de publicación: Estados Unidos

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links